Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

被引:17
作者
Chen, Lei [1 ,2 ]
Kan, Xuefeng [1 ,2 ]
Sun, Tao [1 ,2 ]
Ren, Yanqiao [1 ,2 ]
Cao, Yanyan [1 ,2 ]
Yan, Liangliang [1 ,2 ]
Liang, Bin [1 ,2 ]
Xiong, Bin [1 ,2 ]
Zheng, Chuansheng [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430022, Peoples R China
[2] Hubei Prov Key Lab Mol Imaging, Wuhan 430022, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Iodine; 125; Radiofrequency ablation; Propensity score matching; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; IMPLANTATION; THERAPY; CANCER; TACE;
D O I
10.1186/s12876-020-01355-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Transarterial chemoembolization (TACE), radiofrequency ablation (RFA), and iodine 125 seeds implantation are optional treatments for hepatocellular carcinoma (HCC). The aim of this study is to compare the efficacy of the combined treatment of TACE with iodine 125 seeds implantation (TACE-iodine 125) with TACE with RFA (TACE-RFA) in patients with early- and intermediate-stage HCC. Methods The study included 112 patients who were diagnosed with early- and intermediate-stage HCC from January 1, 2014, to May 31, 2018. Among them, 38 patients were treated with TACE-Iodine 125, and 74 with TACE-RFA. The efficacy of the two treatment groups was retrospectively analyzed. To reduced the selective bias, a propensity score matching (PSM) analysis and inverse probability of treatment weighting (IPTW) method were used to compare the outcomes between the two groups. Results In the absence of PSM and IPTW, the median overall survival (OS) and progression-free survival (PFS) of the TACE-RFA group were slightly longer than those of the TACE-Iodine 125 group (OS: 41 months vs. 36 months; PFS: 18 months vs. 15 months). However, there were no statistically significant differences in the median OS, PFS, and objective response rate (ORR) between the two groups (P > 0.05). After adjusting the age, gender, Child-Pugh class, Barcelona Clinic Liver Cancer (BCLC) stage, and Alpha-fetoprotein (AFP), TACE-Iodine 125 treatment was not associated with a significant increasing the risks of death (HR: 0.763; 95%CI: 0.403,1.345,P = 0.320) and recurrence (HR: 1.020; 95%CI: 0.645,1.611,P = 0.934). After PSM, 35 matched pairs of patients were obtained, and there were no statistically significant differences in the median OS and PFS between the two groups. After IPTW, similar results presented. Conclusions The combination of TACE with iodine 125 seeds implantation may represent an effective treatment for patients with early- and intermediate-stage HCC.
引用
收藏
页数:9
相关论文
共 24 条
[21]   Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial [J].
Yang, MinJie ;
Fang, ZhuTing ;
Yan, ZhiPing ;
Luo, JianJun ;
Liu, LingXiao ;
Zhang, Wen ;
Wu, LinLin ;
Ma, JingQin ;
Yang, QingHui ;
Liu, QingXin .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (02) :211-219
[22]   Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria [J].
Zhang, Lan ;
Yin, Xin ;
Gan, Yu-hong ;
Zhang, Bo-heng ;
Zhang, Ju-bo ;
Chen, Yi ;
Xie, Xiao-ying ;
Ge, Ning-lin ;
Wang, Yan-hong ;
Ye, Sheng-long ;
Ren, Zheng-gang .
BMC GASTROENTEROLOGY, 2014, 14
[23]   Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial [J].
Zhu, Hai-Dong ;
Guo, Jin-He ;
Mao, Ai-Wu ;
Lv, Wei-Fu ;
Ji, Jian-Song ;
Wang, Wen-Hui ;
Lv, Bin ;
Yang, Rui-Min ;
Wu, Wei ;
Ni, Cai-Fang ;
Min, Jie ;
Zhu, Guang-Yu ;
Chen, Li ;
Zhu, Mei-Ling ;
Dai, Zhen-Yu ;
Liu, Peng-Fei ;
Gu, Jian-Ping ;
Ren, Wei-Xin ;
Shi, Rui-Hua ;
Xu, Gao-Feng ;
He, Shi-Cheng ;
Deng, Gang ;
Teng, Gao-Jun .
LANCET ONCOLOGY, 2014, 15 (06) :612-619
[24]   Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis [J].
Zhu, Ze-Xin ;
Wang, Xiao-Xue ;
Yuan, Ke-Fei ;
Huang, Ji-Wei ;
Zeng, Yong .
HPB, 2018, 20 (09) :795-802